Citazione APA

Kato, Y., Ninomiya, K., Ohashi, K., Tomida, S., Makimoto, G., Watanabe, H., . . . Kiura, K. (2018). Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions. Cancer Sci.

Stile di citazione Chicago

Kato, Yuka, et al. "Combined Effect of Cabozantinib and Gefitinib in Crizotinib‐resistant Lung Tumors Harboring ROS1 Fusions." Cancer Sci 2018.

Citazione MLA

Kato, Yuka, et al. "Combined Effect of Cabozantinib and Gefitinib in Crizotinib‐resistant Lung Tumors Harboring ROS1 Fusions." Cancer Sci 2018.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.